Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2014/631642 http://scihub22266oqcxt.onion/10.1155/2014/631642 C4052087!4052087 !24955364     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24955364 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Biomed+Res+Int 2014 ; 2014 (ä): 631642 Nephropedia Template TP {{tp|p=24955364 |t=2014. Antiviral perspectives for chikungunya virus |pdf=|usr=}}{{24955364 }} gab.com Text Antiviral perspectives for chikungunya virus JO: Biomed Res Int http://www.kidney.de/pget.php?&tw=1&pmid=24955364 #FOAvip Chikungunya virus (CHIKV) is a mosquito-borne pathogen that has a major health impact in humans and causes acute febrile illness in humans accompanied by joint pains and, in many cases, persistent arthralgia lasting for weeks to years. CHIKV reemerged in 2005-2006 in several parts of the Indian Ocean islands and India after a gap of 32 years, causing millions of cases. The re-emergence of CHIKV has also resulted in numerous outbreaks in several countries in the eastern hemisphere, with a threat to further expand in the near future. However, there is no vaccine against CHIKV infection licensed for human use, and therapy for CHIKV infection is still mainly limited to supportive care as antiviral agents are yet in different stages of testing or development. In this review we explore the different perspectives for chikungunya treatment and the effectiveness of these treatment regimens and discuss the scope for future directions. Twit Text FOAVip Antiviral perspectives for chikungunya virus ????Biomed Res Int http://www.kidney.de/pget.php?&tw=1&pmid=24955364 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24955364 #FOAvip English Wikipedia <ref>{{Cite pmid|24955364 }}</ref> Antiviral perspectives for chikungunya virus #MMPMID24955364 Parashar D ; Cherian S Biomed Res Int 2014[]; 2014 (ä): 631642 PMID24955364 show ga Chikungunya virus (CHIKV) is a mosquito-borne pathogen that has a major health impact in humans and causes acute febrile illness in humans accompanied by joint pains and, in many cases, persistent arthralgia lasting for weeks to years. CHIKV reemerged in 2005-2006 in several parts of the Indian Ocean islands and India after a gap of 32 years, causing millions of cases. The re-emergence of CHIKV has also resulted in numerous outbreaks in several countries in the eastern hemisphere, with a threat to further expand in the near future. However, there is no vaccine against CHIKV infection licensed for human use, and therapy for CHIKV infection is still mainly limited to supportive care as antiviral agents are yet in different stages of testing or development. In this review we explore the different perspectives for chikungunya treatment and the effectiveness of these treatment regimens and discuss the scope for future directions. |*Disease Outbreaks [MESH] |Animals [MESH] |Chikungunya Fever/*epidemiology/transmission/virology [MESH] |Chikungunya virus/genetics/*pathogenicity [MESH] |Culicidae/virology [MESH] |Humans [MESH]Antiviral perspectives for chikungunya virus (epmc).pdf DeepDyve Pubget Overpricing